Detalhe da pesquisa
1.
The DNA Methylcytosine Dioxygenase Tet2 Sustains Immunosuppressive Function of Tumor-Infiltrating Myeloid Cells to Promote Melanoma Progression.
Immunity
; 47(2): 284-297.e5, 2017 08 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-28813659
2.
sFRP2 in the aged microenvironment drives melanoma metastasis and therapy resistance.
Nature
; 532(7598): 250-4, 2016 Apr 14.
Artigo
em Inglês
| MEDLINE | ID: mdl-27042933
3.
Stem cell-released oncolytic herpes simplex virus has therapeutic efficacy in brain metastatic melanomas.
Proc Natl Acad Sci U S A
; 114(30): E6157-E6165, 2017 07 25.
Artigo
em Inglês
| MEDLINE | ID: mdl-28710334
4.
Corrigendum: sFRP2 in the aged microenvironment drives melanoma metastasis and therapy resistance.
Nature
; 537(7619): 254, 2016 Sep 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-27383789
5.
Structure of Vps75 and implications for histone chaperone function.
Proc Natl Acad Sci U S A
; 105(34): 12206-11, 2008 Aug 26.
Artigo
em Inglês
| MEDLINE | ID: mdl-18723682
6.
Site-specific introduction of an acetyl-lysine mimic into peptides and proteins by cysteine alkylation.
J Am Chem Soc
; 132(29): 9986-7, 2010 Jul 28.
Artigo
em Inglês
| MEDLINE | ID: mdl-20608637
7.
TLR Stimulation Produces IFN-ß as the Primary Driver of IFN Signaling in Nonlymphoid Primary Human Cells.
Immunohorizons
; 4(6): 332-338, 2020 06 18.
Artigo
em Inglês
| MEDLINE | ID: mdl-32554437
8.
Novel Protocol for Generating Physiologic Immunogenic Dendritic Cells.
J Vis Exp
; (147)2019 05 17.
Artigo
em Inglês
| MEDLINE | ID: mdl-31157760
9.
Increased Serine Synthesis Provides an Advantage for Tumors Arising in Tissues Where Serine Levels Are Limiting.
Cell Metab
; 29(6): 1410-1421.e4, 2019 06 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-30905671
10.
A novel immunogenic mouse model of melanoma for the preclinical assessment of combination targeted and immune-based therapy.
Sci Rep
; 9(1): 1225, 2019 02 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-30718660
11.
Extracorporeal Photochemotherapy Drives Monocyte-to-Dendritic Cell Maturation to Induce Anticancer Immunity.
Cancer Res
; 78(14): 4045-4058, 2018 07 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-29764863
12.
DKK2 imparts tumor immunity evasion through ß-catenin-independent suppression of cytotoxic immune-cell activation.
Nat Med
; 24(3): 262-270, 2018 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-29431745
13.
Myeloid-targeted immunotherapies act in synergy to induce inflammation and antitumor immunity.
J Exp Med
; 215(3): 877-893, 2018 03 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-29436395
14.
UV-induced somatic mutations elicit a functional T cell response in the YUMMER1.7 mouse melanoma model.
Pigment Cell Melanoma Res
; 30(4): 428-435, 2017 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-28379630
15.
The YUMM lines: a series of congenic mouse melanoma cell lines with defined genetic alterations.
Pigment Cell Melanoma Res
; 29(5): 590-7, 2016 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-27287723
16.
DNMT3b Modulates Melanoma Growth by Controlling Levels of mTORC2 Component RICTOR.
Cell Rep
; 14(9): 2180-2192, 2016 Mar 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-26923591
17.
Co-inhibition of colony stimulating factor-1 receptor and BRAF oncogene in mouse models of BRAFV600E melanoma.
Oncoimmunology
; 5(3): e1089381, 2016 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-27141346
18.
Response to Programmed Cell Death-1 Blockade in a Murine Melanoma Syngeneic Model Requires Costimulation, CD4, and CD8 T Cells.
Cancer Immunol Res
; 4(10): 845-857, 2016 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-27589875
19.
BRAF Inhibition Decreases Cellular Glucose Uptake in Melanoma in Association with Reduction in Cell Volume.
Mol Cancer Ther
; 14(7): 1680-92, 2015 Jul.
Artigo
em Inglês
| MEDLINE | ID: mdl-25948295
20.
The broad-spectrum receptor tyrosine kinase inhibitor dovitinib suppresses growth of BRAF-mutant melanoma cells in combination with other signaling pathway inhibitors.
Pigment Cell Melanoma Res
; 28(4): 417-30, 2015 Jul.
Artigo
em Inglês
| MEDLINE | ID: mdl-25854919